94 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
HETEROCYCLIC DERIVATIVES AS JANUS KINASE INHIBITORS

Chiesi Farmaceutici
BI-ARYL DIHYDROOROTATE DEHYDROGENASE INHIBITORS

Janssen Biotech
SMALL-MOLECULE MODULATORS OF THE ORPHAN NUCLEAR RECEPTOR TLX

Baylor College Of Medicine
MODIFIED IMIDAZOPYRIDINES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

Merck Sharp & Dohme
Glutarimides for medical treatment

C4 Therapeutics
Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine

Kronos Bio
DACOS type NNRTIS amino acid ester derivative, preparation method thereof, pharmaceutical composition, and application thereof

Yunnan University
Benzimidazole and indole compounds and uses thereof

Incyte
Piperidinone formyl peptide 2 receptor and formyl peptide 1 receptor agonists

Bristol-Myers Squibb
Pyridazinone compounds and their use as DAAO inhibitors

Takeda Pharmaceutical
Substituted isoquionline derivatives as immunomudulators

Bristol-Myers Squibb
Pyrimidine FGFR4 inhibitors

Eisai R&D Management
Inhibitors of tryptophan dioxygenases (IDO1 and TDO) and their use in therapy

Auckland Uniservices
Amino acid compounds and methods of use

Pliant Therapeutics
Spirocycle compounds and methods of making and using same

Lundbeck La Jolla Research Center
Substituted [5,6]cyclic-4(3H)-pyrimidinones as anticancer agents

Zenji Research Laboratories
Pyridine derivatives and their use in the treatment of cancer and hemoglobinopathies

Ctxt
PD-1/PD-L1 inhibitors

Gilead Sciences
Imidazolepyridine compounds and uses thereof

Novartis
Spiro-condensed pyrrolidine derivatives as deubiquitylating enzymes (DUB) inhibitors

Mission Therapeutics
Multi-tyrosine kinase inhibitors derivatives and methods of use

Ontogenesis
Heterocyclylmethyl-thienouracile as antagonists of the adenosine-A2B-receptor

Bayer Pharma Aktiengesellschaft
HDAC inhibitors

Biomarin Pharmaceutical
Tricyclic PI3K inhibitor compounds and methods of use

Genentech
Triaza-spirodecanones as DDR1 inhibitors

Hoffmann-La Roche
Substituted oxopyridine derivatives

Bayer Pharma Aktiengesellschaft
Amino-triazolopyridine compounds and their use in treating cancer

Astrazeneca
Substituted 4-phenylpiperidines, their preparation and use

Columbia University
Compounds and compositions as toll-like receptor 7 agonists

Novartis
Indolin-2-one derivatives

Hoffmann-La Roche
Cinnoline derivatives useful as CB-1 receptor inverse agonists

Janssen Pharmaceutica
Pyrrolidine orexin receptor antagonists

Merck Sharp & Dohme
Pyrazole compounds as CB2 agonists

Hoffmann-La Roche
Use of T1R3 venus flytrap region polypeptide to screen for taste modulators

Senomyx
C2-azaspiro iminothiazine dioxides as BACE inhibitors, compositions, and their use

Merck Sharp & Dohme
5-azaindazole compounds and methods of use

F. Hoffmann-La Roche
Tetrahydro-pyrimidoazepines as modulators of TRPV1

Janssen Pharmaceutica
Synthesis and characterization of 5,7-dihydroxyflavanone derivatives as novel protein tyrosine phosphatase 1B inhibitors.

Yanbian University College of Pharmacy
Substituted [1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists

Euroscreen
Substituted benzimidazoles

Bayer Intellectual Property
Design, synthesis, and urease inhibition studies of some 1,3,4-oxadiazoles and 1,2,4-triazoles derived from mandelic acid.

Quaid-I-Azam University
Structural basis for the recognition of peptide RJPXD33 by acyltransferases in lipid A biosynthesis.

University of Michigan
Compounds as tyrosine kinase modulators

Allergan
Design, synthesis, cyclooxygenase inhibition and biological evaluation of new 1,3,5-triaryl-4,5-dihydro-1H-pyrazole derivatives possessing amino/methanesulfonyl pharmacophore.

Beni-Suef University
Inhibition of Pax2 Transcription Activation with a Small Molecule that Targets the DNA Binding Domain.

University of Michigan
Heat Capacity Changes for Transition-State Analogue Binding and Catalysis with Human 5'-Methylthioadenosine Phosphorylase.

Albert Einstein College of Medicine
Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase BTK inhibitors

University of Utah Research Foundation
Role of the two structural domains from the periplasmic Escherichia coli histidine-binding protein HisJ.

University of Calgary
Inhibitors of Furin and other pro-protein convertases

Sanford-Burnham Medical Research Institute
3,4-dihydropyrrolo[1,2-A]pyrazine-2,8(1H)-dicarboxamide derivatives, preparation thereof and therapeutic use thereof for diseases involving casein kinase 1 epsilon and/or casein kinase 1 delta

Sanofi
Chromane compounds

Comentis
Heteroaryl compounds and uses thereof

Celgene Avilomics Research
Phosphoinositide 3-kinase inhibitors

Respivert
Design, synthesis, and biological characterization of tamibarotene analogs as anticancer agents.

Shandong University
Novel N-allyl/propargyl tetrahydroquinolines: Synthesis via Three-component Cationic Imino Diels-Alder Reaction, Binding Prediction, and Evaluation as Cholinesterase Inhibitors.

Universidad De Talcaa
Tyrosine kinase inhibitors

Principia Biopharma
Dihydroxy aromatic heterocyclic compound

Takeda Pharmaceutical
Molecular docking studies and biological evaluation of 1,3,4-thiadiazole derivatives bearing Schiff base moieties as tyrosinase inhibitors.

Shaoyang University
Triazole compounds that modulate Hsp90 activity

Synta Pharmaceuticals
Haematopoietic-prostaglandin D2 synthase inhibitors

The University of Queensland
TSH receptor antagonizing tetrahydroquinoline compounds

Merck Sharp & Dohme
Mediators of hedgehog signaling pathways, compositions and uses related thereto

Curis
Transcriptional Profiling of a Selective CREB Binding Protein Bromodomain Inhibitor Highlights Therapeutic Opportunities.

Pfizer
Factor IXa inhibitors

Merck Sharp & Dohme
Substituted 3,4-dihydropyrrolo[1,2-a]pyrazin-1(2H)-ones as protein kinase inhibitors

Nerviano Medical Sciences
Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skin

The Procter & Gamble
Amino-heteroaryl 7-hydroxy-spiropiperidine indolinyl antagonists of P2Y1 receptor

Bristol-Myers Squibb
Substituted pyrido[3,2-E][1,2,4]-triazolo[4,3-A]pyrazines for the treatment of central nervous system disorders

Boehringer Ingelheim International
Heteroaryl sodium channel inhibitors

Amgen
Tricyclic pyrazol amine derivatives

Merck Serono
Solid-Supported Synthesis and 5-HT7 /5-HT1A Receptor Affinity of Arylpiperazinylbutyl Derivatives of 4,5-dihydro-1,2,4-triazine-6-(1H)-one.

Jagiellonian University Medical College
Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof

Kissei Pharmaceutical
Agents for reversing epigenetic silencing of genes

The Johns Hopkins University
Dimethylarginine dimethylaminohydrolase inhibitors and methods of use thereof

The Leland Stanford Junior University
N1/N2-lactam acetyl-CoA carboxylase inhibitors

Pfizer
Morpholinyl derivatives useful as MOGAT-2 inhibitors

Eli Lilly
Selective androgen receptor modulators

Radius Health
Heterocyclic derivatives

Novartis
Selective glycosidase inhibitors and uses thereof

Simon Fraser University
Pyrimidine-substituted pyrrolidine derivatives, pharmaceutical compositions and uses thereof

Boehringer Ingelheim International
Bicyclic compounds and their uses as dual c-SRC/JAK inhibitors

Debiopharm
Substituted imidazopyridines as HDM2 inhibitors

Merck Sharp & Dohme
Inhibitors of syk and JAK protein kinases

Portola Pharmaceuticals
Heteroaromatic compounds as BTK inhibitors

Boehringer Ingelheim International
Compounds for the inhibition of integrins and use thereof

Shire Orphan Therapies
Depsipeptides and their therapeutic use

Karus Therapeutics
Heterocyclic pyrazole compounds, method for preparing the same and use thereof

Development Center For Biotechnology
Quinoline carboxamide derivatives as protein tyrosine kinase inhibitors

Novartis
TRPV1 antagonists

Abbvie
Pyrazolothiazole compound

Eisai R&D Management
Pyrrolidine derivatives

Hoffmann-La Roche
Selective indole-based ECE inhibitors: synthesis and pharmacological evaluation.

Bayer Healthcare